drugset / Trial / NCT05170919
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether olanzapine or mirtazapine is more effective in preventing weight loss and appetite loss in cancer patients.
Timeline
- Start
- 2022-01-20
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | 15 mg | — |
| Subject | Olanzapine | Small molecule | 2.5 mg | — |
| Subject | Olanzapine | Small molecule | 5 mg | — |